Ketamine as Adjunctive Analgesic With Bupivacaine in Paravertebral Analgesia for Breast Cancer Surgery
Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
This study aims to investigate the safety and the analgesic efficacy of adding Ketamine to
bupivacaine 0.25% in thoracic PVB in patients undergoing modified radical mastectomy.